ArticleCureus2026
Complete vs Near-Complete Reperfusion After Endovascular Therapy for Anterior-Circulation Large-Core Stroke: Propensity-Matched 90-Day Outcomes and Collateral-Modified Time Effects.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn endovascular therapy (EVT)-treated anterior-circulation large-core stroke, the incremental value of complete reperfusion modified thrombolysis in cerebral infarction (mTICI 3) over near-complete reperfusion (mTICI 2b) is unclear, and collateral physiology may modify time-related tissue injury and recovery.
methodsThis retrospective cohort included adults with anterior-circulation large-vessel occlusion, Alberta Stroke Program Early CT Score (ASPECTS) of 3-5, successful reperfusion (mTICI: ≥2b), pretreatment diffusion-weighted imaging (DWI) core volumetry, and 90-day outcome data (n = 106). A 1:1 propensity score match compared final mTICI 2b versus final mTICI 3 (matched n = 84; 42 per group). Prespecified interaction models tested with American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) collateral grade as an effect modifier of onset-to-reperfusion time.
resultsThe mTICI 2b group required more thrombectomy passes (median: 2 vs 1; p < 0.001). Functional independence (modified Rankin Scale (mRS): 0 to 2) was similar for mTICI 2b versus mTICI 3 (10/42 (23.8%) vs 11/42 (26.2%); adjusted odds ratio (OR): 1.21; p = 0.66). Symptomatic intracranial hemorrhage (sICH) was higher with mTICI 2b (6/42 (14.3%) vs 2/42 (4.8%); p = 0.04), while 90-day mortality was similar (15/42 (35.7%) vs 13/42 (31.0%); p = 0.75). A longer onset-to-reperfusion time was associated with a larger DWI core (+5.8 cc per hour; p = 0.01) and lower odds of functional independence (OR: 0.78 per hour; p = 0.04). Higher collateral grade was associated with smaller core (-8.4 cc per grade; p = 0.02) and higher odds of independence (OR: 2.5 per grade; p = 0.01). Time × collateral interactions were significant for core (β -2.1; p = 0.03) and independence (OR: 1.19; p = 0.04).
conclusionsIn large-core endovascular therapy (EVT) with successful reperfusion, mTICI 3 did not improve 90-day functional outcomes versus mTICI 2b but was associated with fewer symptomatic hemorrhages, supporting physiology-informed urgency and counselling in this high-risk population. Procedural escalation beyond mTICI 2b should be individualized in large cores overall.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.